This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Aventis Pharma S.a.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Marc Peschanski: Innovator in Gene Therapy
Introduction
Marc Peschanski is a notable inventor based in Créteil, France. He has made significant contributions to the field of gene therapy, particularly through his work with adenovirus vectors. With a total of 2 patents, Peschanski's innovations are paving the way for advancements in the treatment of central nervous system diseases.
Latest Patents
Peschanski's latest patents focus on the use of adenovirus vectors for gene transfer into the central nervous system. The first patent describes a recombinant DNA vector capable of directing the expression and/or transcription of a selected nucleotide sequence in central nervous system cells. This vector includes parts of the adenovirus genome necessary for cell penetration and is designed to operate under the control of a promoter. This invention holds promise for treating various diseases of the central nervous system and is particularly relevant in the field of gene therapy.
The second patent also revolves around a recombinant DNA vector with similar characteristics. It emphasizes the operability of promoters in central nervous system cells, further enhancing the potential for effective gene therapy applications. Both patents highlight Peschanski's commitment to advancing medical science through innovative solutions.
Career Highlights
Marc Peschanski is currently associated with Aventis Pharma S.A., where he continues to contribute to groundbreaking research in gene therapy. His work has garnered attention for its potential impact on treating neurological disorders, showcasing his dedication to improving patient outcomes through scientific innovation.
Collaborations
Peschanski has collaborated with esteemed colleagues such as Axel Kahn and Gildas Le Gal La Salle. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.
Conclusion
Marc Peschanski's contributions to gene therapy through his patents and collaborations underscore his role as a leading inventor in the field. His work continues to inspire advancements in medical science, particularly in the treatment of central nervous system diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile